KCL22/NOD-SCID 小鼠慢性粒细胞白血病移植瘤模型的建立及其鉴定

时间:2022-12-08 02:24:36 阅读: 最新文章 文档下载
说明:文章内容仅供预览,部分内容可能不全。下载后的文档,内容与下面显示的完全一致。下载之前请确认下面内容是否您想要的,是否完整无缺。
KCL22NOD-SCID 小鼠慢性粒细胞白血病移植瘤模型的建

立及其鉴定

文良雪;刘鑫;李会;黄宁姝;黄峥兰;冯文莉

【期刊名称】《中国实验动物学报》 【年(),期】2015(000)002

【摘 要】Objective To investigate the potential of chronic myeloid leukemia ( CML) cell line KCL22 in indu-cing leukemia in NOD-SCID mice for setting up a basis for constructing a CML mouse transplantation tumor model. Methods 2 ×107 KCL22 cells in logarithmic growth phase were injected via the tail vein into experimental NOD-SCID mice whereas PBS was injected to the mice of control group.General condition of the mice of both groups was observed.Wright staining was used to observe the changes of blood and bone marrow smears.PCR was conducted to detect the transcription level of BCR-ABL, and histology with HE staining was used to evaluate the tumor cell invasion in the liver and spleen. Results Four weeks after the injection of KCL22 cells, the mice in experimental group showed physical signs of decreased reactivity, depression, swollen hindlimb muscles and petechia on the hindlimb femur.Peripheral white blood cells ( WBC) began to increase after 5 weeks, with a significantly increased quantity compared with the control group (P<0.05).Imma-ture granulocytes could be seen in blood and bone marrow smears, and tumor cell infiltration was found in the liver and spleen.BCR-ABL was highly


expressed in bone marrow cells.Survival time of the experimental mice without therapy was 70 days, significantly shorter than that in the control group ( >90 days) (P<0.05).Conclusions A NOD-SCID mouse model of CML transplantation tumor is successfully established with leukemia KCL22 cells.%目的:研究人慢性粒细胞白血病细胞株KCL22NOD-SCID小鼠体内致白血病的能力,为慢性粒细胞白血病血液移植瘤模型鼠的建立奠定基础。方法取对数生长期的KCL22细胞2×107个,经尾静脉注射入NOD-SCID小鼠,对照组小鼠注射无菌PBS。观察小鼠一般情况,瑞氏染色监测血象和骨髓象变化,PCR检测骨髓细胞BCR-ABL基因转录水平,HE染色观察肝、脾组织肿瘤细胞浸润情况。结果实验组小鼠于注射细胞后约4周开始出现反应力下降、精神萎靡、股骨肌肿大、后肢骨节出血点等体征,外周血白细胞从第5周逐渐增多,计数较对照组显著升高( P0.05),血涂片可见幼稚粒细胞,肝、脾、骨髓组织切片可见白血病细胞浸润,骨髓细胞高表达BCR-ABL融合基因,未经治疗存活约70天,较对照组显著缩短( P0.05)。结论 KCL22细胞可成功构建NOD-SCID小鼠慢性粒细胞白血病移植瘤模型。 【总页数】6(P188-193)

【作 者】文良雪;刘鑫;李会;黄宁姝;黄峥兰;冯文莉

【作者单位】重庆医科大学检验医学院,临床检验诊断学教育部重点实验室,重庆 400016;重庆医科大学检验医学院,临床检验诊断学教育部重点实验室,重庆 400016;重庆医科大学检验医学院,临床检验诊断学教育部重点实验室,重庆 400016;重庆医科大学检验医学院,临床检验诊断学教育部重点实验室,重庆 400016;重庆医科大学检验医学院,临床检验诊断学教育部重点实验室,重庆


400016;重庆医科大学检验医学院,临床检验诊断学教育部重点实验室,重庆 400016

【正文语种】 【中图分类】Q95-33 【相关文献】

1.建立BCR-ABL逆转录病毒介导的小鼠慢性粒细胞白血病模型的实验条件优化 [J], 张文萍;韩红星;杨燕;陈荣贵;单万水

2.多药耐药细胞系K562/A02裸小鼠皮下移植瘤模型的建立与鉴定 [J], 王树滨;;刘桂英;杨铭;杨纯正

3.稳定过表达IL-9的小鼠CT-26肿瘤细胞株及BALB/C小鼠皮下移植瘤模型的建 [J], 王进;董晓强;赵鑫;朱新国;赵华;张江磊

4.C57BL6近交系小鼠前列腺癌原位移植瘤模型建立及比较 [J], 张政;张欣;付启航;岳悦;王雷雷;陈辉;徐阳阳

5.耐紫杉醇肺原位小鼠移植瘤模型的建立和鉴定 [J], 杨晓华;郭莉莉;路丽明

因版权原因,仅展示原文概要,查看原文内容请购买


本文来源:https://www.wddqw.com/doc/6b12900f834d2b160b4e767f5acfa1c7aa0082db.html